Litcius/Paper detail

Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad

Preethika Ekanayake, Christopher J. Hupfeld, Sunder Mudaliar

2020Current Diabetes Reports32 citationsDOI

Topics & Concepts

KetogenesisCotransporterSodiumEndocrinologyInternal medicineChemistryType 2 diabetesMedicineDiabetes mellitusKetone bodiesMetabolismOrganic chemistryDiabetes Treatment and ManagementPancreatic function and diabetesMetabolism, Diabetes, and Cancer
Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad | Litcius